0001415889-24-017531.txt : 20240618 0001415889-24-017531.hdr.sgml : 20240618 20240618210829 ACCESSION NUMBER: 0001415889-24-017531 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240617 FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tsai Philip CENTRAL INDEX KEY: 0002026600 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 241053809 MAIL ADDRESS: STREET 1: C/O IMMUNOME, INC. STREET 2: 18702 NORTH CREEK PARKWAY, SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 4 1 form4-06192024_010626.xml X0508 4 2024-06-17 0001472012 Immunome Inc. IMNM 0002026600 Tsai Philip C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100 BOTHELL WA 98011 false true false false Chief Technology Officer 0 Stock option (right to buy) 13.15 2024-06-17 4 A 0 250000 0 A 2034-06-16 Common Stock 250000 250000 D 25% of the shares subject to the options vest on June 17, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter. /s/ Sandra Stoneman, Attorney-in-Fact 2024-06-18